A. Tabernero et al., Modelling the changes dare to the endothelium and hypertension in the alpha-adenoreceptor-mediated responses of rat aorta, J AUT PHARM, 19(4), 1999, pp. 219-228
1 The present study focuses on the role of endothelium on alpha(1)-adrenoce
ptor-mediated vasoconstriction in aorta from Wistar Kyoto (WKY) and spontan
eously hypertensive rats (SHR). To define and quantify changes in the param
eters governing agonism at alpha(1)-adrenoceptor by hypertension and/or end
othelium, the operational model of analysis was used.
2 In either endothelium intact or denuded aorta, the sensitivity (P < 0.001
) and the maximum contraction (P < 0.05) to phenylephrine were smaller in S
HR than in WKY.
3 However, in each strain of rats, removal of endothelium increased the sen
sitivity (P < 0.001) to phenylephrine but reduced (P < 0.05) KCl-evoke vaso
constriction, suggesting a modulation of these responses by the endothelium
. The observed differences in sensitivity and maximum contraction are inter
preted in terms of the operational parameters: E-m, the maximum possible ef
fect; pK(A), the agonist affinity; alpha, the agonist efficacy and n, the s
lope for the function relating receptor occupancy to pharmacological effect
The estimated parameters reflected differences, between strains, in the si
gnal transduction processes linked to alpha(1)-adrenoceptor stimulation asc
ribed to the presence of the endothelium.
4 N-G-nitro-L-arginine methyl ester (L-NAME), enhanced to a similar extend
in both rat strains the sensitivity (P < 0.001) and the maximum contraction
to phenylephrine. Indomethacin reduced the maximum contraction to phenylep
hrine by 56.85% in SHR and by 11.80% in WKY suggesting that contracting pro
stanoids play a more major role in this response in SHR than in WKY. Nevert
heless, these inhibitors were without effect on denuded vessels from both s
trains suggesting that NO and cyclooxygenase products from the media of the
adventitia do not play a role on the phenylephrine-mediated responses.
5 The studied endothelial factors partially explain the observed difference
s in modulation of alpha(1)-adrenoceptor responses by the endothelium but s
uggest the participation of other compounds released by the endothelium.